Intermittent ADT has QoL advantage in advanced prostate cancer
Researchers say that intermittent androgen deprivation therapy may be preferable to conventional continuous treatment for some men with advanced prostate cancer.
Source: MedWire News - Urology - Category: Urology & Nephrology Source Type: news